marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-02-2023
ImmunoGen Balance Sheet 2011-2024 | IMGN
Annual Balance Sheet ImmunoGen
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-260 M | -460 M | - | -149 M | -260 M | -265 M | -145 M | -278 M | -142 M | -195 M | -161 M | -191 M |
Long Term Debt |
11.1 M | 15.2 M | - | 2.08 M | 2.06 M | 2.05 M | 100 M | - | - | - | - | - |
Long Term Debt Current |
4.1 M | 3.54 M | 3.15 M | 2.97 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 234 M | 214 M | 257 M | 308 M | 243 M | 68.4 M | 72.6 M | 80.2 M | 63.1 M |
Total Current Liabilities |
122 M | 101 M | 122 M | 77.4 M | 70.7 M | 55.8 M | 55.8 M | 35.8 M | 21.3 M | 19.2 M | 16.3 M | - |
Total Liabilities |
193 M | 200 M | 266 M | 311 M | 284 M | 313 M | 369 M | 279 M | 89.6 M | 91.7 M | 96.4 M | 77.7 M |
Deferred Revenue |
13.9 M | 44.4 M | 29.2 M | 309 K | 317 K | 1.4 M | 13.6 M | 333 K | 2.37 M | 1.49 M | 3.33 M | 3.32 M |
Retained Earnings |
-1.69 B | -1.47 B | -1.33 B | -1.29 B | -1.18 B | -1.03 B | -854 M | -709 M | -648 M | -577 M | -504 M | -431 M |
Total Assets |
349 M | 526 M | 355 M | 235 M | 295 M | 295 M | 287 M | 314 M | 165 M | 214 M | 180 M | 218 M |
Cash and Cash Equivalents |
275 M | 479 M | 294 M | 176 M | 262 M | 267 M | 160 M | 245 M | 142 M | 195 M | 161 M | 191 M |
Book Value |
156 M | 326 M | 89.6 M | -76.1 M | 11 M | -17.9 M | -82.3 M | 35.1 M | 75.7 M | 122 M | 83.9 M | 140 M |
Total Shareholders Equity |
156 M | 326 M | 89.6 M | -76.1 M | 11 M | -17.9 M | -153 M | 35.1 M | 75.7 M | 122 M | 83.9 M | 140 M |
All numbers in USD currency
Quarterly Balance Sheet ImmunoGen
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
7.76 M | 8.92 M | 10 M | 11.1 M | 12.2 M | - | 14.3 M | 15.2 M | 16 M | 17 M | 17.9 M | 18.7 M | 18.7 M | 2.08 M | 2.08 M | 2.08 M | 2.08 M | 2.08 M | 2.08 M | 2.06 M | 2.06 M | 2.06 M | 2.06 M | 2.05 M | 2.05 M | 2.05 M | 2.05 M | 97 M | 97 M | 97 M | 96.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
261 M | 223 M | 166 M | 193 M | 181 M | - | 175 M | 200 M | 220 M | 233 M | 252 M | 266 M | 266 M | 266 M | 266 M | 311 M | 311 M | 311 M | 311 M | 284 M | 284 M | 284 M | 284 M | 313 M | 313 M | 313 M | 313 M | 352 M | 352 M | 352 M | 362 M | 268 M | 274 M | 273 M | 279 M | 51.1 M | 84.1 M | 89.6 M | 89.6 M | 72.5 M | 80.6 M | 91.7 M | 91.7 M | 94.8 M | 95.4 M | 96.4 M | 96.4 M | 92.9 M | 75.3 M | 77.7 M | 77.7 M |
Deferred Revenue |
37.2 M | 14.4 M | 13.4 M | 13.9 M | 15.1 M | - | 23.4 M | 44.4 M | 53.5 M | 53.8 M | 51.5 M | 29.2 M | 29.2 M | 29.2 M | 29.2 M | 309 K | 309 K | 309 K | 309 K | 317 K | 317 K | 317 K | 317 K | 1.4 M | 27.1 M | 26.2 M | 1.81 M | 14.5 M | 14.5 M | 14.5 M | 13.6 M | 1.54 M | 858 K | 333 K | 333 K | 1.11 M | 23.7 M | 2.37 M | 2.37 M | 2.52 M | 2.26 M | 1.49 M | 1.49 M | 1.3 M | 1.38 M | 2.35 M | 2.35 M | 3.39 M | 3.85 M | 2.35 M | 2.35 M |
Retained Earnings |
-1.71 B | -1.74 B | -1.74 B | -1.69 B | -1.64 B | - | -1.5 B | -1.47 B | -1.43 B | -1.4 B | -1.37 B | -1.33 B | -1.33 B | -1.33 B | -1.33 B | -1.29 B | -1.29 B | -1.29 B | -1.29 B | -1.18 B | -1.18 B | -1.18 B | -1.18 B | -1.03 B | -1.03 B | -1.03 B | -1.03 B | -933 M | -933 M | -933 M | -854 M | -776 M | -743 M | -709 M | -709 M | -657 M | -670 M | -648 M | -648 M | -584 M | -588 M | -577 M | -577 M | -554 M | -529 M | -504 M | -504 M | -463 M | -450 M | -431 M | -431 M |
Total Assets |
822 M | 714 M | 288 M | 349 M | 359 M | - | 482 M | 526 M | 297 M | 301 M | 346 M | 355 M | 355 M | 355 M | 355 M | 235 M | 235 M | 235 M | 235 M | 295 M | 295 M | 295 M | 295 M | 295 M | 295 M | 295 M | 295 M | 199 M | 199 M | 199 M | 279 M | 252 M | 286 M | 308 M | 314 M | 129 M | 143 M | 165 M | 165 M | 203 M | 200 M | 214 M | 214 M | 231 M | 253 M | 180 M | 180 M | 208 M | 199 M | 218 M | 218 M |
Cash and Cash Equivalents |
606 M | 572 M | 201 M | 275 M | 310 M | 374 M | 438 M | 479 M | 246 M | 240 M | 283 M | 294 M | 294 M | 294 M | 294 M | 176 M | 176 M | 176 M | 176 M | 262 M | 262 M | 262 M | 262 M | 267 M | 267 M | 267 M | 267 M | 160 M | 160 M | 160 M | 196 M | 212 M | 248 M | 212 M | 248 M | 107 M | 122 M | 107 M | 122 M | 178 M | 175 M | 178 M | 175 M | 211 M | 234 M | 211 M | 234 M | 168 M | 180 M | 168 M | 180 M |
Book Value |
562 M | 491 M | 122 M | 156 M | 178 M | - | 306 M | 326 M | 77.1 M | 68.5 M | 94.1 M | 89.6 M | 89.6 M | 89.6 M | 89.6 M | -76.1 M | -76.1 M | -76.1 M | -76.1 M | 11 M | 11 M | 11 M | 11 M | -17.9 M | -17.9 M | -17.9 M | -17.9 M | -153 M | -153 M | -153 M | -82.3 M | -16.7 M | 11.6 M | 35.1 M | 35.1 M | 77.5 M | 59 M | 75.7 M | 75.7 M | 130 M | 119 M | 122 M | 122 M | 136 M | 157 M | 83.9 M | 83.9 M | 115 M | 124 M | 140 M | 140 M |
Total Shareholders Equity |
562 M | 491 M | 122 M | 156 M | 178 M | 250 M | 306 M | 326 M | 77.1 M | 68.5 M | 94.1 M | 89.6 M | 89.6 M | 89.6 M | 89.6 M | -76.1 M | -76.1 M | -76.1 M | -76.1 M | 11 M | 11 M | 11 M | 11 M | -17.9 M | -17.9 M | -17.9 M | -17.9 M | -153 M | -153 M | -153 M | -82.3 M | -16.7 M | 11.6 M | 35.1 M | 35.1 M | 77.5 M | 59 M | 75.7 M | 75.7 M | 130 M | 119 M | 122 M | 122 M | 136 M | 157 M | 83.9 M | 83.9 M | 115 M | 124 M | 140 M | 140 M |
All numbers in USD currency